Publications

ESC Working Group on Pulmonary Circulation & Right Ventricular Function

The Working Group on Pulmonary Circulation and Right Ventricular Function is involved in different scientific publications.

Position Papers and Consensus Documents

Access Papers >

Recommended Reading

Date

Title

Date: 2023

Title: A multimodality imaging approach to defining risk in patients with acute pulmonary embolism
Date: 2023

Title: Prediction of very early major bleeding risk in acute pulmonary embolism: an independent external validation of the PE-SARD Bleeding Score
Date: 2023

Title: Long-term inhaled treprostinil for PH-ILD: INCREASE open-label extension study
Date: 2023

Title: Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension
Date: 2023

Title: Catheter-Directed Thrombolysis vs Anticoagulation in Patients With Acute Intermediate-High-risk Pulmonary Embolism: The CANARY Randomized Clinical Trial
Date: 2023

Title: Prognostic implications of atrial vs. ventricular functional tricuspid regurgitation
Date: 2023

Title: Management of COVID-19 in Patients with Pulmonary Arterial Hypertension
Date: 2023

Title: Sotatercept for the treatment of pulmonary arterial hypertension: PULSAR open-label extension
Date: 2023

Title: Pre-existing chronic thromboembolic pulmonary hypertension in acute pulmonary embolism
Date: 2022

Title: Milvexian for the prevention of venous thromboembolism
Date: 2022

Title: Safety and efficiency of diagnostic strategies for ruling out pulmonary embolism in clinically relevant patient subgroups : a systematic review and individual-patient data meta-analysis
Date: 2022

Title: Effect of antiplatelet therapy on survival and organ support-free days in critically ill patients with COVID-19: a randomized clinical trial
Date: 2022

Title: Determinants of altered left ventricular suction in pre-capillary pulmonary hypertension
Date: 2021

Title: Risk for Recurrent Venous Thromboembolism in Patients With Subsegmental Pulmonary Embolism Managed Without Anticoagulation : A Multicenter Prospective Cohort Study
Date: 2021

Title: The impact of comorbidities on selexipag treatment effect in patients with pulmonary arterial hypertension: insights from the GRIPHON study
Date: 2021

Title: COMPERA 2.0: A refined 4-strata risk assessment model for pulmonary arterial hypertension
Date: 2021

Title: Temporal trends in pulmonary arterial hypertension: Results from the COMPERA registry
Date: 2021

Title: Clinical features and survival in Takayasu's arteritis-associated pulmonary hypertension: a nationwide study
Date: 2021

Title: Triaging acute pulmonary embolism for home treatment by Hestia or simplified PESI criteria: the HOME-PE randomized trial
Date: 2021

Title: Association Between Initial Treatment Strategy and Long-term Survival in Pulmonary Arterial Hypertension
Date: 2021

Title: Characteristics and outcomes of patients with chronic thromboembolic pulmonary hypertension in the era of modern therapeutic approaches: data from the Polish multicenter registry (BNP-PL)
Date: 2021

Title: PH CARE COVID survey: an international patient survey on the care for pulmonary hypertension patients during the early phase of the COVID-19 pandemic
Date: 2021

Title: Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit The INSPIRATION Randomized Clinical Trial
Date: 2021

Title: Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19: JACC State-of-the-Art Review
Date: 2021

Title: Incidence of thrombotic complications and overall survival in hospitalized patients with COVID-19 in the second and first wave
Date: 2021

Title: Pulmonary hypertension in patients with chronic obstructive lung disease: results from COMPERA
Date: 2020

Title: Standardized exercise training is feasible, safe, and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension: results from a large European multicentre randomized controlled trial
Date: 2020

Title: One-Year Echocardiographic, Functional, and Quality of Life Outcomes After Ultrasound-Facilitated Catheter-Based Fibrinolysis for Pulmonary Embolism
Date: 2020

Title: EXPRESS: Rethinking COVID-19 ‘pneumonia’ – Is this primarily a vaso-occlusive disease, and can early anticoagulation save the ventilator famine?
Date: 2020

Title: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up
Date: 2020

Title: Diagnosis of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism
Date: 2020

Title: Care of patients with Pulmonary Arterial Hypertension during the Coronavirus (COVID-19) Pandemic
Date: 2020

Title: Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy
Date: 2020

Title: Systemic Consequences of Pulmonary Hypertension and Right-Sided Heart Failure
Date: 2020

Title: Early discharge and home treatment of patients with low-risk pulmonary embolismwith the oral factor Xa inhibitor rivaroxaban: an international multicentre single-armclinical trial
Date: 2020

Title: Familial pulmonary arterial hypertension by KDR heterozygous loss of function
Date: 2019

Title: Screening strategies for pulmonary arterial hypertension
Date: 2019

Title: Clinical outcomes of patients with pulmonary embolism versus deep vein thrombosis: From the COMMAND VTE Registry
Date: 2019

Title: 2019 updated consensus statement on the diagnosis and treatment of pediatric pulmonary hypertension: The European Pediatric Pulmonary Vascular Disease Network (EPPVDN), endorsed by AEPC, ESPR and ISHLT
Date: 2019

Title: Hospital volume and outcomes for acute pulmonary embolism: multinational population based cohort study
Date: 2019

Title: A Multicenter Trial of Vena Cava Filters in Severely Injured Patients
Date: 2019

Title: Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Date: 2019

Title: Macitentan for the treatment of portopulmonary hypertension (PORTICO): a multicentre, randomised, double-blind, placebo-controlled, phase 4 trial
Date: 2019

Title: Trends in thrombolytic treatment and outcomes of acute pulmonary embolism in Germany
Date: 2019

Title: Association of N-Terminal Pro Brain Natriuretic Peptide and Long-Term Outcome in Patients With Pulmonary Arterial Hypertension
Date: 2019

Title: Anatomy, Function, and Dysfunction of the Right Ventricle
Date: 2019

Title: Balloon pulmonary angioplasty for the treatment of residual or recurrent pulmonary hypertension after pulmonary endarterectomy
Date: 2019

Title: Proposed new pulmonary hypertension definition: is 4 mm(Hg) worth re-writing medical textbooks?
Date: 2019

Title: The new haemodynamic definition of pulmonary hypertension: evidence prevails, finally!
Date: 2018

Title: Clinical and Hemodynamic Factors in Predicting Response to Fluid Challenge during Right Heart Catheterization
Date: 2018

Title: Discordance between Imaging Modalities in the Evaluation of Chronic Thromboembolic Pulmonary Hypertension: A Combined Experience from Two Academic Medical Centers
Date: 2018

Title: Balloon pulmonary angioplasty for the treatment of residual or recurrent pulmonary hypertension after pulmonary endarterectomy
Date: 2018

Title: Value of lung perfusion scintigraphy in patients with idiopathic pulmonary arterial hypertension: a patchy pattern to consider
Date: 2018

Title: Hemodynamics of the diastolic pressure gradients in acute heart failure: Implications for the diagnosis of pre-capillary pulmonary hypertension in left heart disease

ESC Guidelines

Date

Title

Date: 2023

Title: Endocarditis
Date: 2022

Title: Pulmonary Hypertension
Date: 2019

Title: Acute Pulmonary Embolism

Comments on publications

Date

Title

Show navigation Hide navigation

Publications

ESC Working Group on Pulmonary Circulation & Right Ventricular Function

Position Papers and Consensus Documents